[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-SU-ICT-2018-2020Pillar: Industrial LeadershipOpening Date: Deadline: Tue, 29 May 2018 17:00:00 (Brussels local time)Modification Date: Wed, 30 May 2018Latest information: On 29 May 2018, call H2020-SU-ICT-2018-2 closed at 17:00.
13 proposals were submitted in totalto thetopic SU-ICT-03-2018 (RIA).
The 2018 BIO World Congress on Industrial Biotechnology is quickly approaching, but before the partnering begins in Philadelphia BIO will be focusing on industrial biotechnology at the 2018 International Convention in Boston, June 4-7, 2018.
Programming at BIO’s International Convention will include sessions on Biofuels & Renewable Chemicals on Tuesday, June 5 starting at 11 a.m. Here’s a rundown for what to expect for each program:
Advances in Renewable Chemicals
11 am – noon, Room 255, Level 2
Renewable chemical companies are using new techniques – including synthetic biology and automation – to rapidly move from initial target identification to production of a desired renewable chemical. Several renewable chemical companies will present new methods to improve efficiency and efficacy in renewable chemical manufacturing. Panelists include:
Moderator: Kevin Jarrell, CEO, Modular Genetics
Speakers:
Sustainable Aviation Fuel Taking Off!
3 – 4 pm, Room 255, Level 2
In May 2018, Boeing successfully flew the first commercial jet on 100 percent biofuel, flying from Seattle to Memphis and back. In this session, a panel of experts will discuss how biofuels are transforming the aviation industry and what the future holds. Panelists include:
Moderator: Todd Campbell, Development Advisor, CC: Clean Economy Works
Speakers:
Designing Renewable Specialty Chemicals as Pharmaceutical Intermediates from Synthetic Biology
4:15 pm – 5:15 pm, Room 255, Level 2
Suppliers of active pharmaceutical ingredients (APIs) are looking to reduce cost and shorten time to market. As pharmaceutical manufacturers find their margins under pressure, they continue to look for ways to reduce cost through partnerships with industrial biotechnology companies that develop novel metabolic pathways to quality pharmaceutical intermediates. Panelists include:
Moderator: Brian Baynes, CEO, MODO Global
Speakers:
In addition, BIO will be hosting a panel to discuss cellular agriculture and how Industrial Biotechnology is brewing protein! Panelists include:
Moderator: Vince Sewalt, Sr. Director, Product Stewardship & Regulatory, DuPont Industrial Biosciences
Speakers:
For a full rundown of industrial biotechnology and other programming visit http://convention.bio.org/program/. For more information about the 2018 BIO International Convention visit http://convention.bio.org.
Zombie hunter character Rick Grimes may finally meet his end on the hit AMC horror series. But who will fill his bloody shoes?
[Read More …]
Earlier this month, we held our annual “Meet the Xconomists” reception in Boston. This event is where we invite a mix of business leaders across tech, life sciences, and other sectors to network and trade ideas with our informal editorial advisors (we call them the Xconomists).
It’s always a great crowd, and this year’s was extra special to me, as I was celebrating my 10th work anniversary at Xconomy. (My first two years were spent mostly in Seattle).
Big thanks to our hosts Underscore VC for opening up their space in Boston’s Old City Hall building for the party. A… Read more »
UNDERWRITERS AND PARTNERS
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: HERCULE-LT-AG-2018Pillar: HERCULE-1-1Opening Date: Deadline: Thu, 14 Jun 2018 17:00:00 (Brussels local time)Modification Date: Tue, 29 May 2018Latest information: IMPORTANT MESSAGEfor the applicants who downloaded the budget form (Excel file) related to this HERCULE III call for proposals before 29 May 2018 at 11:10.
The previous Excel budget form had an incorrect formula in calculating the amount of the EU grant.
For those who downloaded the budget form before 29 May at 11.10, please download again the form in order to ensure the correct calculation of the maximum EU grant amount.
IMPORTANT MESSAGEfor the applicants who downloaded documents related to the three HERCULE III calls for proposals before 4 May 2018 at 15:00.
Due to a technical error, the HERCULE III-related downloadable documents available on the participant portal were incorrect until 4 May 2018.
These documents pertained to 2017 Call for Proposals, not the current Call of 2018.
If you have downloaded the documents before 4 May at 15:00, you are requested to download THE UPDATED VERSION of these documents.
In less than a week more than 16,500 people will descend on Boston to form partnerships and collaborations that could one day dramatically change our lives for the better. This year BIO will be celebrating its 25th anniversary so its Convention is appropriately themed “Make History”, a subtle reference to this historic milestone as well as the rich history of Boston.
Any veteran of BIO’s International Convention can tell you: It’s a lot.
There are keynotes, fireside chats, super sessions, breakout sessions, company presentations, partnering, a patient pavilion with 62 patient groups, a start-up stadium, an emerging innovators zone, international and state pavilions, hundreds of exhibitors-the list goes on. And don’t forget Diana Ross!
What’s the best way to navigate? First and foremost, make myBIO your best friend now. You can download the app in the Apple or Google stores or use it on your computer. It is a great resource for everything happening at convention. (Note: myBIO is separate from BIO One-on-One Partnering). Here are some highlights to what you can do!
Tip: Use the “filter” function for sessions, attendees, and companies. For more information and tips visit http://convention.bio.org/myBIO
There are three resources in our online Toolkit – feel free to browse the Onsite Guide, Education Grid, BIO Exhibition Map and Yelp Guide in advance of arriving onsite here.
Your journey through #BIO2018 is your own but here are some highlights by day
But in this brainy city, home to perhaps the world’s leading biotechnology cluster and a lot of avid runners, the path to success for some is a 4½-mile …
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-BG-2018-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Wed, 4 Sep 2019 17:00:00 (Brussels local time)Modification Date: Mon, 28 May 2018Latest information:
For the 2018 two-stage topics of this call (i.e. BG-08-2018-2019 sub-scope B; BG-08-2018-2019 sub-scope C and LC-BG-03-2018), related generalised feedbacks are published. Please see the update on the topic page.
Avrobio and Eidos Therapeutics, rare disease drug developers on opposite sides of the country, have filed for initial public offerings, each company aiming to raise cash to finance more clinical tests of its lead drug.
Cambridge, MA-based Avrobio set a preliminary $86 million target for its IPO, according to its prospectus filed Friday. The gene therapy developer has applied for a listing on the Nasdaq under the stock symbol “AVRO.” Eidos Therapeutics of San Francisco, which develops treatments for a family of rare diseases linked to the buildup of a certain protein in the body, set an initial IPO goal of… Read more »
UNDERWRITERS AND PARTNERS
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: PADR-EF-2018Pillar: Preparatory Action on Defence Research (PADR)Opening Date: Deadline: Thu, 28 Jun 2018 17:00:00 (Brussels local time)Modification Date: Fri, 25 May 2018Latest information: We have updated the document with the topic relatedfrequently asked questions- see the topic conditions section below.
